Jones, Karen L.

Gastroparesis

Camilleri, M., Chedid, V., Ford, A. C., Haruma, K., Horowitz, M., Jones, K. L., Low, P. A., Park, S.-Y., Parkman, H. P., & Stanghellini, V. (2018) · Nature Reviews Disease Primers

Gastrointestinal motility and disordersGastrointestinal Bleeding Diagnosis and Treatment

Cited by 411

Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones

Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Diabetes Care

Gastrointestinal motility and disordersDiabetes Treatment and Management

Cited by 335

Gastric emptying in diabetes: clinical significance and treatment

Horowitz, M., O’Donovan, D., Jones, K. L., Feinle, C., Rayner, C. K., & Samsom, M. (2002) · Diabetic Medicine

Gastrointestinal motility and disordersDiabetes Management and Research

Cited by 308

Gastric emptying and glycaemia in health and diabetes mellitus

Phillips, L. K., Deane, A. M., Jones, K. L., Rayner, C. K., & Horowitz, M. (2015) · Nature Reviews Endocrinology

Gastrointestinal motility and disordersDiabetes Management and Research

Cited by 273

Comparative Effects of Prolonged and Intermittent Stimulation of the Glucagon-Like Peptide 1 Receptor on Gastric Emptying and Glycemia

Umapathysivam, M. M., Lee, M. Y., Jones, K. L., Annink, C. E., Cousins, C. E., Trahair, L. G., Rayner, C. K., Chapman, M. J., Nauck, M. A., Horowitz, M., et al. (2014) · Diabetes

Diabetes Treatment and ManagementGastrointestinal motility and disorders

Cited by 193

Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes

Horowitz, M., Flint, A., Jones, K. L., Hindsberger, C., Rasmussen, M. F., Kapitza, C., Doran, S., Jax, T., Zdravkovic, M., & Chapman, I. M. (2012) · Diabetes Research and Clinical Practice

Diabetes Treatment and ManagementRegulation of Appetite and Obesity

Cited by 179

Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans

Wu, T., Zhao, B. R., Bound, M. J., Checklin, H. L., Bellon, M., Little, T. J., Young, R. L., Jones, K. L., Horowitz, M., & Rayner, C. K. (2012) · The American Journal of Clinical Nutrition

Diabetes Treatment and ManagementBiochemical Analysis and Sensing Techniques

Cited by 163

Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions

Jalleh, R. J., Rayner, C. K., Hausken, T., Jones, K. L., Camilleri, M., & Horowitz, M. (2024) · The Lancet Gastroenterology & Hepatology

Diabetes Treatment and ManagementGastrointestinal motility and disorders

Cited by 144

Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function

Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2011) · Experimental Diabetes Research

Diabetes Treatment and ManagementGastrointestinal motility and disorders

Cited by 138

Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: Relationship to glycemia*

Deane, A. M., Chapman, M. J., Fraser, R. J. L., Summers, M. J., Zaknic, A. V., Storey, J. P., Jones, K. L., Rayner, C. K., & Horowitz, M. (2010) · Critical Care Medicine

Diabetes Treatment and ManagementClinical Nutrition and Gastroenterology

Cited by 104

The effect of short-term dietary supplementation with glucose on gastric emptying of glucose and fructose and oral glucose tolerance in normal subjects

Horowitz, M., Cunningham, K. M., Wishart, J. M., Jones, K. L., & Read, N. W. (1996) · Diabetologia

Gastrointestinal motility and disordersDiabetes Treatment and Management

Cited by 102

Glucagon-like peptides 1 and 2 in health and disease: A review

Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Peptides

Diabetes Treatment and ManagementRegulation of Appetite and Obesity

Cited by 100

Diabetic Gastroparesis: Diagnosis and Management

Ma, J., Rayner, C. K., Jones, K. L., & Horowitz, M. (2009) · Drugs

Gastrointestinal motility and disordersDiabetes Treatment and Management

Cited by 87

Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control

Jalleh, R. J., Jones, K. L., Rayner, C. K., Marathe, C. S., Wu, T., & Horowitz, M. (2022) · Diabetologia

Gastrointestinal motility and disordersDiabetes Treatment and Management

Cited by 87

The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: A randomized controlled trial

Thazhath, S. S., Marathe, C. S., Wu, T., Chang, J., Khoo, J., Kuo, P., Checklin, H. L., Bound, M. J., Rigda, R. S., Crouch, B., et al. (2016) · Diabetes

Diabetes Treatment and ManagementGastrointestinal motility and disorders

Cited by 83

Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes

Jones, K. L., Rigda, R. S., Buttfield, M. D. M., Hatzinikolas, S., Pham, H. T., Marathe, C. S., Wu, T., Lange, K., Trahair, L. G., Rayner, C. K., et al. (2019) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 66

Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility

Jalleh, R. J., Marathe, C. S., Rayner, C. K., Jones, K. L., Umapathysivam, M. M., Wu, T., Quast, D. R., Plummer, M. P., Nauck, M. A., & Horowitz, M. (2024) · Endocrinology

Diabetes Treatment and ManagementGastrointestinal motility and disorders

Cited by 61

Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes

Horowitz, M., Rayner, C. K., & Jones, K. L. (2013) · Advances in Therapy

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 58

Disease-specific education in the primary care setting increases the knowledge of people with chronic obstructive pulmonary disease: A randomized controlled trial

Hill, K., Mangovski-Alzamora, S., Blouin, M., Guyatt, G., Heels-Ansdell, D., Bragaglia, P., Tamari, I., Jones, K., & Goldstein, R. (2010) · Patient Education and Counseling

Chronic Obstructive Pulmonary Disease (COPD) ResearchNursing care and research

Cited by 54

Gastrointestinal autonomic neuropathy in diabetes

Marathe, C. S., Jones, K. L., Wu, T., Rayner, C. K., & Horowitz, M. (2020) · Autonomic Neuroscience

Gastrointestinal motility and disordersCardiovascular Syncope and Autonomic Disorders

Cited by 38

Prognosis of diabetic gastroparesis—a 25-year evaluation

Chang, J., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Diabetic Medicine

Gastrointestinal motility and disordersGastrointestinal Bleeding Diagnosis and Treatment

Cited by 37

Glucagon‐like peptide‐1 receptor agonists and the appropriate measurement of gastric emptying

Horowitz, M., Rayner, C. K., Marathe, C. S., Wu, T., & Jones, K. L. (2020) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementGastrointestinal motility and disorders

Cited by 32

Hypoglycaemia and gastric emptying

Marathe, C. S., Marathe, J. A., Rayner, C. K., Kar, P., Jones, K. L., & Horowitz, M. (2019) · Diabetes, Obesity and Metabolism

Diabetes Management and ResearchGastrointestinal motility and disorders

Cited by 32

Accurate Measurements of Gastric Emptying and Gastrointestinal Symptoms in the Evaluation of Glucagon-like Peptide-1 Receptor Agonists

Jalleh, R. J., Jones, K. L., Nauck, M., & Horowitz, M. (2023) · Annals of Internal Medicine

Gastrointestinal motility and disordersDiabetes Treatment and Management

Cited by 18